News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
NASDAQ Golden Dragon China Index Spikes 8.5%; Bilibili Rallies 22%
The meeting of the Political Bureau of the CPC Central Committee studied economic work for 2025 and propounded the implementation of a more proactive fiscal policy and a modestly l...
Reset
Send
The window will close in 5 seconds
NASDAQ Golden Dragon China Index Spikes 8.5%; Bilibili Rallies 22%
Close
Recommend
4
Positive
10
Negative
10
 
SHORT SELL
 
STOCK INFO

The meeting of the Political Bureau of the CPC Central Committee studied economic work for 2025 and propounded the implementation of a more proactive fiscal policy and a modestly loose monetary policy. Chinese ADRs advanced in the US. The NASDAQ Golden Dragon China Index soared 584 pts or 8.5% to 7,425. The index saw 7,569 during the session with upswing of 10.6% at one point.

Online brokerage stocks swelled, with UP Fintech (TIGR.US)      and Futu (FUTU.US)      leaping 26.3% and 17.8%. Among automakers, ZEEKR (ZK.US)      , Xpeng (XPEV.US)      and Nio (NIO.US)      spiked 13.4%, 13% and 12.4%, while Li Auto (LI.US)      rallied 8%.

Related NewsByteDance Negates 2025 Capex at RMB150B
Among the dotcoms, Bilibili (BILI.US)      shot up 21.6%. iQiyi (IQ.US)      , Vipshop (VIPS.US)      , JD.com (JD.US)      and NetEase (NTES.US)      mounted 10.6-11.8%. New Oriental (EDU.US)      and Trip.com (TCOM.US)      surged 9.6% and 8.7%. Baidu (BIDU.US)      , Weibo (WB.US)      and Alibaba (BABA.US)      jumped up 7.4-7.6%.
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.